“`html
Merit Medical Systems, Inc. (MMSI) reported third-quarter 2025 adjusted earnings per share (EPS) of 92 cents, marking a 6.9% increase year-over-year and exceeding the Zacks Consensus Estimate by 12.2%. GAAP EPS for the quarter was 46 cents, down 4.2% from the previous year. Revenue reached $384.2 million, up 13% year-over-year, surpassing estimates by 3.5%.
U.S. sales were $230.6 million, an increase of 11.7%, while international sales totaled $153.6 million, up 15.2%. The Cardiovascular segment generated $366.4 million, up 13.5%, with notable revenue contributions from the Cardiac Intervention category, which rose 29.3%. Merit Medical ended the quarter with $392.5 million in cash and equivalents, compared to $341.8 million at the second-quarter end.
For 2025, Merit Medical projects net revenues between $1.502 billion and $1.515 billion, an increase of 10.7%-11.7% year-over-year. Adjusted EPS guidance was raised to a range of $3.66 to $3.79, reflecting a growth of 6%-10%. The Zacks Consensus Estimate for revenues for 2025 is pegged at $1.50 billion.
“`
